Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Malignancies

Explore clinical trials studying Advanced Solid Malignancies. Study availability and eligibility vary by location and protocol.

47 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Malignancies trial results

Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

NCT06028074

Conditions
Advanced Solid Malignancies
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View Trial Details
Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

NCT05417594

Conditions
Adnexal Diseases, Advanced Solid Malignancies, Astrocytoma, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Chicago, Illinois, United States
View all 32 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

NCT07223047

Conditions
Advanced Solid Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +24 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • NEXT Oncology San Antonio, Texas, United States
  • START Mountain Region West Valley City, Utah, United States
  • NEXT Virginia Fairfax, Virginia, United States
View Trial Details
Recruiting

A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors

NCT05315167

Conditions
Advanced Solid Malignancies, Advanced Solid Tumor, Congenital Abnormalities, +10 more
Locations
  • The first affiliated hospital of Zhengzhou University Zhengzhou, Henan, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
  • Cancer hospital of the University of Chinese Academy of Sciences Hangzhou, Zhejiang, China
  • Beijing Cancer Hospital Beijing, China
View Trial Details
Active, not recruiting

A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

NCT05159700

Conditions
Advanced Solid Malignancies, Advanced Solid Tumor, Congenital Abnormalities, +10 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
  • Christ Hospital Cincinnati, Ohio, United States
  • NEXT Oncology Austin, Texas, United States
View Trial Details

Related conditions